218 related articles for article (PubMed ID: 7558161)
1. Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock.
Nicoletti F; Zaccone P; Di Marco R; Magro G; Grasso S; Morrone S; Santoni A; Tempera G; Meroni PL; Bendtzen K
Immunology; 1995 Aug; 85(4):645-50. PubMed ID: 7558161
[TBL] [Abstract][Full Text] [Related]
2. Sodium fusidate ameliorates the course of diabetes induced in mice by multiple low doses of streptozotocin.
Nicoletti F; Di Marco R; Conget I; Gomis R; Edwards C; Papaccio G; Bendtzen K; Sandler S
J Autoimmun; 2000 Dec; 15(4):395-405. PubMed ID: 11090238
[TBL] [Abstract][Full Text] [Related]
3. Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor.
Nicoletti F; Di Marco R; Barcellini W; Magro G; Schorlemmer HU; Kurrle R; Lunetta M; Grasso S; Zaccone P; Meroni P
Eur J Immunol; 1994 Aug; 24(8):1843-7. PubMed ID: 8056041
[TBL] [Abstract][Full Text] [Related]
4. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide.
Qin HY; Singh B
J Autoimmun; 1997 Jun; 10(3):271-8. PubMed ID: 9218754
[TBL] [Abstract][Full Text] [Related]
5. MFP14, a multifunctional emerging protein with immunomodulatory properties, prevents spontaneous and recurrent autoimmune diabetes in NOD mice.
Panerai AE; Nicoletti F; Sacedote P; Arvidsson L; Conget I; Gomis R; Bartorelli A; Sandler S
Diabetologia; 2001 Jul; 44(7):839-47. PubMed ID: 11508268
[TBL] [Abstract][Full Text] [Related]
6. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae.
Saï P; Rivereau AS
Diabetes Metab; 1996 Oct; 22(5):341-8. PubMed ID: 8896996
[TBL] [Abstract][Full Text] [Related]
7. Superantigen and endotoxin synergize in the induction of lethal shock.
Blank C; Luz A; Bendigs S; Erdmann A; Wagner H; Heeg K
Eur J Immunol; 1997 Apr; 27(4):825-33. PubMed ID: 9130631
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
O'Brien BA; Harmon BV; Cameron DP; Allan DJ
J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
[TBL] [Abstract][Full Text] [Related]
9. Lazaroid antioxidant reduces incidence of diabetes and insulitis in nonobese diabetic mice.
Rabinovitch A; Suarez WL; Power RF
J Lab Clin Med; 1993 Apr; 121(4):603-7. PubMed ID: 8454942
[TBL] [Abstract][Full Text] [Related]
10. MyD88-dependent pro-inflammatory cytokine response contributes to lethal toxicity of staphylococcal enterotoxin B in mice.
Kissner TL; Ruthel G; Cisney ED; Ulrich RG; Fernandez S; Saikh KU
Innate Immun; 2011 Oct; 17(5):451-62. PubMed ID: 20699281
[TBL] [Abstract][Full Text] [Related]
11. Reduction of spontaneous autoimmune diabetes in diabetes-prone BB rats with the novel immunosuppressant fusidic acid. Effect on T-cell proliferation and production of interferon-gamma.
Nicoletti F; Di Marco R; Morrone S; Zaccone P; Lembo D; Grasso S; Santoni A; Meroni PL; Bendtzen K
Immunology; 1994 Feb; 81(2):317-21. PubMed ID: 8157281
[TBL] [Abstract][Full Text] [Related]
12. Lack of autoimmune serological reactions in rodent models of insulin dependent diabetes mellitus.
Mackay IR; Bone A; Tuomi T; Elliott R; Mandel T; Karopoulos C; Rowley MJ
J Autoimmun; 1996 Dec; 9(6):705-11. PubMed ID: 9115572
[TBL] [Abstract][Full Text] [Related]
13. Islet T cells secreting IFN-gamma in NOD mouse diabetes: arrest by p277 peptide treatment.
Ablamunits V; Elias D; Reshef T; Cohen IR
J Autoimmun; 1998 Feb; 11(1):73-81. PubMed ID: 9480725
[TBL] [Abstract][Full Text] [Related]
14. NOD fetal thymus organ culture: an in vitro model for the development of T cells involved in IDDM.
Wilson SS; DeLuca D
J Autoimmun; 1997 Oct; 10(5):461-72. PubMed ID: 9376074
[TBL] [Abstract][Full Text] [Related]
15. Effect of prophylactic insulin treatment on the number of ER-MP23+ macrophages in the pancreas of NOD mice. Is the prevention of diabetes based on beta-cell rest?
Jansen A; Rosmalen JG; Homo-Delarche F; Dardenne M; Drexhage HA
J Autoimmun; 1996 Jun; 9(3):341-8. PubMed ID: 8816969
[TBL] [Abstract][Full Text] [Related]
16. Analysis of action mechanism of lymphotoxin in prevention of cyclophosphamide-induced diabetes in NOD mice.
Takahashi K; Satoh J; Sagara M; Zhu XP; Muto G; Muto Y; Fukuzawa M; Nishimura S; Miyaguchi S; Toyata T
J Autoimmun; 1995 Jun; 8(3):335-46. PubMed ID: 7575995
[TBL] [Abstract][Full Text] [Related]
17. Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-gamma secretion pathway.
Ablamunits V; Quintana F; Reshef T; Elias D; Cohen IR
J Autoimmun; 1999 Dec; 13(4):383-92. PubMed ID: 10585754
[TBL] [Abstract][Full Text] [Related]
18. Lethal outcome caused by Porphyromonas gingivalis A7436 in a mouse chamber model is associated with elevated titers of host serum interferon-gamma.
Huang JH; Lin YY; Lai YY; Hu SW
Oral Microbiol Immunol; 2006 Apr; 21(2):100-6. PubMed ID: 16476019
[TBL] [Abstract][Full Text] [Related]
19. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
Yoshida K; Kikutani H
Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
[TBL] [Abstract][Full Text] [Related]
20. Fusidin ameliorates experimental autoimmune myocarditis in rats by inhibiting TNF-alpha production.
Milenkovć M; Arsenović-Ranin N; Vucićević D; Bufan B; Stojić-Vukanić Z
Pharmazie; 2007 Jun; 62(6):445-8. PubMed ID: 17663192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
